Strs Ohio Aveo Pharmaceuticals, Inc. Transaction History

Strs Ohio

  • $23.2 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 25, 2021
SELL
$5.08 - $6.68 $62,484 - $82,164
-12,300 Closed
0 $0
Q3 2020

Dec 14, 2020
SELL
$4.16 - $6.26 $113,152 - $170,272
-27,200 Reduced 68.86%
12,300 $73,000
Q2 2020

Jul 23, 2020
BUY
$3.47 - $9.99 $137,065 - $394,605
39,500 New
39,500 $203,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email